指南与共识支持与姑息治疗

ReCOG关于多次放疗累积剂量评估与报告标准的共识声明

Reirradiation Collaborative Group (ReCOG) consensus on standards for dose evaluation and reporting in patients with multiple courses of radiation therapy: an AAPM/ACRO/ASTRO/CARO/COMP/CADRA/CPQR/ESTRO/NRG-endorsed consensus statement.
指南 / 共识 · Lancet Oncol · 2026-01-01

该共识由ReRT协作组(ReCOG)组织国际多学科专家制定,获AAPM/ACRO/ASTRO/CARO/COMP/CADRA/CPQR/ESTRO/NRG背书,提出再放疗中剂量累积评估、记录与报告的框架,涵盖基于图像配准和点剂量的方法,并强调机构工作流、软件工具及纵向结局采集。

要点

  • 推荐采用图像配准与点剂量结合的方法进行多次放疗的累积剂量评估。
  • 需考虑数据可得性、器官生理恢复和解剖变化等不确定性因素。
  • 强调机构工作流标准化、软件工具改进及跨专科协作。

核心结论

  • 再放疗需标准化累积剂量评估与报告方法,以优化治疗并促进多学科整合。

研究设计与样本

  • 国际多学科协作组(ReCOG)制定的共识声明,获多个学会背书。

主要发现

  • 提出基于图像配准和点剂量的剂量累积实用策略,并考虑数据不确定性、器官恢复和解剖变化。
  • 强调机构工作流、软件工具改进和纵向患者结局采集的重要性。
  • 指出需改进生物学模型、数据基础设施和跨专科协作。

关键数值与推荐

  • 推荐采用图像配准和点剂量方法进行多次放疗的累积剂量评估。
  • 评估时应考虑数据可得性、生理器官恢复和解剖变化的不确定性。
  • 强调机构工作流、软件工具和纵向结局采集的标准化。

临床怎么用

  • 在再放疗临床决策中,应系统评估既往放疗剂量并记录累积剂量。
  • 建议机构建立标准化工作流,采用软件工具辅助剂量累积。
  • 鼓励跨专科协作以优化再放疗患者管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As cancer survivors live longer, technologies improve, and reirradiation (reRT) becomes more common, standardised methods for the assessment and reporting of cumulative radiation doses are needed to allow treatment optimisation and integration with other medical specialties managing these complex patients. This consensus statement, developed by an international collaboration of radiation oncologists, physicists, and other experts in the Reirradiation Collaborative Group, proposes a framework for consistent evaluation, documentation, reporting, and clinical decision making in reRT. This paper outlines practical strategies for dose accumulation from multiple courses of radiation therapy with the use of both image registration-based and point dose-based methods, accounting for uncertainties in data availability, physiological organ recovery, and anatomical changes. The emphasis of the consensus statement is on institutional workflows, improved software tools, and better capture of longitudinal patient outcomes. We also highlight the need for improved biological models, data infrastructure, and cross-specialty collaboration. Ultimately, reRT is framed as a transformative challenge for oncology, demanding interdisciplinary innovation across science, clinical care, and health systems. Widespread adoption of these recommendations could accelerate progress toward improved outcomes for patients receiving reRT worldwide.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Paradis KC, Appelt AL, Bentzen SM, et al. Reirradiation Collaborative Group (ReCOG) consensus on standards for dose evaluation and reporting in patients with multiple courses of radiation therapy: an AAPM/ACRO/ASTRO/CARO/COMP/CADRA/CPQR/ESTRO/NRG-endorsed consensus statement. Lancet Oncol. 2026. PMID: 41643699. doi:10.1016/S1470-2045(25)00562-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。